Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Net Income (Quarterly): -36.61M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -36.61M |
| March 31, 2024 | 2.172B |
| December 31, 2023 | 1.440B |
| September 30, 2023 | -4.975B |
| June 30, 2023 | -2.058B |
| March 31, 2023 | 2.339B |
| December 31, 2022 | 624.76M |
| September 30, 2022 | 550.03M |
| June 30, 2022 | -317.42M |
| March 31, 2022 | 3.693B |
| December 31, 2021 | 1.328B |
| September 30, 2021 | 100.22M |
| June 30, 2021 | -2.814B |
| March 31, 2021 | 2.517B |
| December 31, 2020 | 367.23M |
| September 30, 2020 | -3.209B |
| June 30, 2020 | -10.52B |
| March 31, 2020 | 1.643B |
| December 31, 2019 | 1.566B |
| September 30, 2019 | 1.152B |
| June 30, 2019 | 453.85M |
| March 31, 2019 | 1.410B |
| December 31, 2018 | -4.477B |
| September 30, 2018 | 3.338B |
| June 30, 2018 | 948.05M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.400B |
| December 31, 2017 | 174.28M |
| September 30, 2017 | 4.563B |
| June 30, 2017 | 1.347B |
| March 31, 2017 | 2.219B |
| December 31, 2016 | 488.70M |
| September 30, 2016 | 1.325B |
| June 30, 2016 | 1.559B |
| March 31, 2016 | 1.667B |
| December 31, 2015 | 670.70M |
| September 30, 2015 | 1.110B |
| June 30, 2015 | 1.286B |
| March 31, 2015 | 1.505B |
| December 31, 2014 | 279.75M |
| September 30, 2014 | 1.095B |
| June 30, 2014 | 1.307B |
| March 31, 2014 | 1.950B |
| December 31, 2013 | 619.39M |
| September 30, 2013 | 971.60M |
| June 30, 2013 | 1.098B |
| March 31, 2013 | 1.531B |
| December 31, 2012 | 474.77M |
| September 30, 2012 | 645.09M |
| June 30, 2012 | 617.62M |
| March 31, 2012 | 1.364B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-10.52B
Minimum
Jun 2020
3.693B
Maximum
Mar 2022
-293.90M
Average
550.03M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| CureVac NV | -78.11M |
| Affimed NV | -16.64M |
| InflaRx NV | -19.19M |
| BioNTech SE | 217.87M |
| Immatics NV | -19.41M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.00B |
| Total Expenses (Quarterly) | 11.43B |
| EPS Diluted (Quarterly) | -0.0081 |
| Enterprise Value | 10.49B |
| Gross Profit Margin (Quarterly) | 55.19% |
| Profit Margin (Quarterly) | -0.31% |
| Earnings Yield | -6.54% |
| Operating Earnings Yield | 48.75% |
| Normalized Earnings Yield | -6.538 |